분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2011-09-08 17:07:13 , Hit : 2347
 Researchers Successfully Perform First Injection of Cultured Red Blood Cells in Human Donor

ScienceDaily (Sep. 4, 2011) — For the first time, researchers have successfully injected cultured red blood cells (cRBCs) created from human hematopoietic stem cells (HSCs) into a human donor, according to study results published in Blood, the Journal of the American Society of Hematology (ASH). As the global need for blood continues to increase while the number of blood donors is decreasing, these study results provide hope that one day patients in need of a blood transfusion might become their own donors.

Using HSCs (stem cells that form all blood cell types) from one human donor, a Paris-based research team successfully generated billions of cRBCs in a petri dish with the aid of specific growth factors that regulate the proliferation and maturation of HSCs into red blood cells. Seeking to prove that the cRBCs were capable of reaching full maturation in the body, the researchers then injected the cells into four mouse models and confirmed that the cells were able to progress through the full maturation process. Using a volunteer donor, the researchers then repeated the process of creating another set of cRBCs and injected the cells back into the donor's own body to assess their survival in a human. After five days, the survival rate of the cRBCs in the donor's bloodstream was between 94 and 100 percent and, after 26 days, the rate was between 41 and 63 percent, comparable to the average 28-day half-life of normal native red blood cells. These results demonstrate that the lifespan and survival rate of cultured cells are similar to conventional red blood cells, further supporting their validity as a possible source of transfusion.

"Although previous research has shown that HSCs can be developed into fully matured red blood cells, this is the first study that has proven that they are capable of survival in the human body, a major breakthrough for the transplant community," said Luc Douay, MD, PhD, senior study author and Professor of Hematology at Université Pierre et Marie Curie in Paris, France. "There is a dire need for an alternative source of transfusable blood products, especially with the risk of infection from emergent new viruses that comes with traditional transfusion. Producing red blood cells in culture is promising since other efforts to create alternative sources have not yet been as successful as once hoped."

These results are especially timely, as blood donation organizations such as the American Red Cross have recently declared a critical nationwide blood shortage. Globally, the World Health Organization (WHO) recently reported donation rates of less than 1 percent of the population in more than 70 countries. Many of these countries are considered developing or transitional and have substantial transfusion needs due to high prevalence of maternal morbidity, childhood malnutrition, trauma casualties, and infectious disease.

"The results from our study establish the feasibility of the concept of transfusing cRBCs and show promise that an unlimited blood reserve is within reach," said Professor Douay. "Although the full-scale production of these cells will require additional technological advances in cell engineering, we believe cRBCs could prove to be a valid alternative to classic transfusion products that will not only provide an adequate supply of blood, but reduce the risk of life-threatening complications and infections that can accompany traditional transfusion."

Journal Reference:

Marie-Catherine Giarratana, Hélène Rouard, Agnès Dumont, Laurent Kiger, Innocent Safeukui, Pierre-Yves Le Pennec, Sabine François, Germain Trugnan, Thierry Peyrard, Tiffany Marie, Séverine Jolly, Nicolas Hebert, Christelle Mazurier, Nathalie Mario, Laurence Harmand, Hélène Lapillonne, Jean-Yves Devaux, Luc Douay. Proof of principle for transfusion of in vitro generated red blood cells. Blood, 2011; DOI: 10.1182/blood-2011-06-362038







867   Protein synthesis: Stop the nonsense  이성욱 2011/06/20 2288
866   Regado Biosciences Kicks Off Big Clinical Trial For Heart Drug  이성욱 2013/09/18 3244
865   Regeneron to Use Avalanche Platform in $640M+ Gene Therapy Collaboration  이성욱 2014/05/07 1627
864   Regular Aspirin Intake Halves Cancer Risk, Study Finds  이성욱 2011/11/04 2345
863   Rejected flies turn to booze  이성욱 2012/03/19 2649
862   Repeats protect DNA  이성욱 2010/02/06 4443
861   Reprogrammed cells trigger immune reactions in mice  이성욱 2011/05/20 2107
860   Reprogrammed human blood cells show promise for disease research  이성욱 2010/07/09 2225
859   Reprogrammed Stem Cells Are Rife with Mutations  이성욱 2011/03/04 2230
858   Research on Killer HIV Antibodies Provides Promising New Ideas for Vaccine Design-polyreactivity  이성욱 2010/10/05 2335
857   Research provides new findings on drug delivery with nanoparticles  이성욱 2011/03/07 2341
856   Researchers Develop Gene Therapy That Could Correct a Common Form of Blindness  이성욱 2012/01/27 2732
855   Researchers discover a switch that controls stem cell pluripotency  이성욱 2011/09/21 2317
854   Researchers discover mechanism that could convert certain cells into insulin-making cells  이성욱 2011/05/04 2641
853   Researchers identify potential molecular target to prevent growth of cancer cells  이성욱 2011/09/21 2351
  Researchers Successfully Perform First Injection of Cultured Red Blood Cells in Human Donor  이성욱 2011/09/08 2347
851   Researchers turn adult cells back into stem cells  이성욱 2014/01/30 1621
850   Researchers uncover Fragile X syndrome gene's role in shaping brain  이성욱 2010/05/13 3062
849   Researchers: AIDS virus can hide in bone marrow  이성욱 2010/03/09 3194
848   Resistance to HIV Engineered Via CRISPR  이성욱 2017/08/07 737

[이전 10개] [1].. 21 [22][23][24][25][26][27][28][29][30]..[64] [다음 10개]
 

Copyright 1999-2022 Zeroboard / skin by ROBIN